Al Ani Amer, Tahtamoni Rafeef, Mohammad Yara, Al-Ayoubi Fawzi, Haider Nadeem, Al-Mashhadi Ammar
,College of Medicine, Ajman University, United Arab Emirates.
College of Medicine, Sharjah University, United Arab Emirates.
Ann Med Surg (Lond). 2022 Jul;79:103910. doi: 10.1016/j.amsu.2022.103910. Epub 2022 Jun 8.
One of the challenges of surgery on patients with active SARS-CoV-2(severe acute respiratory syndrome coronavirus 2) infection is the increased risk of postoperative morbidity and mortality.
This study will describe and compare the postoperative morbidity and mortality in asymptomatic patients or those with mild infection with those with severe COVID-19 infection undergoing elective or and emergency surgery.
This is a retrospective study of 37 COVID patients who had the infection 7 days prior to and 30 days after emergency or elective surgery. Patients were divided to two groups. Group1: the asymptomatic or those with mild infection that is diagnosed just before surgery (14 patients). Group 2: those who were admitted to the hospital because of severe COVID-19 and were operated for COVID-19 related complications (23 patients). Morbidity and mortality of both groups was studied.
There was no significant difference in gender between the two groups. There were 5 females (2 in group 1, and 3 in group 2) and 32 males (12 in group 1, and 20 in group 2). Mean age for all patients was 49.8years (38 for group 1 and 57 for group2). Median age for all patients was 50 years (37.5 for group 1 and 57 years for group 2). Sepsis developed in 7 patients (1 patient in group 1 and in 6 patients in group 2). Statistically there was no significant difference in occurrence of sepsis between the two groups. There was a significant difference in the intensive care stay between the two groups (higher in group 2). Four deaths were reported in group 1 and fourteen in group 2. Eighteen out of thirty-seven patients died.
Severity of COVID-19 infection will prolong the hospitalization and ICU stay in surgical patients with no significant effect on mortality.
对活动性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者进行手术的挑战之一是术后发病和死亡风险增加。
本研究将描述并比较无症状或轻度感染患者与患有严重冠状病毒病2019(COVID-19)感染的患者在接受择期或急诊手术后的术后发病率和死亡率。
这是一项对37例COVID患者的回顾性研究,这些患者在急诊或择期手术前7天及术后30天感染。患者分为两组。第1组:无症状或在手术前刚被诊断为轻度感染的患者(14例)。第2组:因严重COVID-19入院并因COVID-19相关并发症接受手术的患者(23例)。研究了两组的发病率和死亡率。
两组患者的性别无显著差异。有5名女性(第1组2名,第2组3名)和32名男性(第1组12名,第2组20名)。所有患者的平均年龄为49.8岁(第1组38岁,第2组57岁)。所有患者的年龄中位数为50岁(第1组37.5岁,第2组57岁)。7例患者发生脓毒症(第1组1例,第2组6例)。两组脓毒症的发生率在统计学上无显著差异。两组在重症监护病房的住院时间有显著差异(第2组更长)。第1组报告4例死亡,第2组报告14例死亡。37例患者中有18例死亡。
COVID-19感染的严重程度将延长外科手术患者的住院时间和在重症监护病房的停留时间,对死亡率无显著影响。